CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
of the study drugs fostamatinib and paclitaxel. This study tests different doses of the drugs to see which doses are safest in people with ovarian...
Phase 1
Washington, District of Columbia, United States and 2 other locations
Gleolan for the real-time detection and visualization of epithelial ovarian cancer tumors during debulking surgery. The st...
Phase 3
Annapolis, Maryland, United States
cancer). This Phase III trial builds on the efficacy and safety data reported in the previous Phase II VIRO-15 trial with promising objecti ...
Phase 3
Silver Spring, Maryland, United States and 23 other locations
of olaparib maintenance monotherapy in relapsed high grade serous ovarian cancer (HGSOC) patients (including patients with primary ...
Phase 3
Baltimore, Maryland, United States and 125 other locations
(CAR) T cells developed by Precigen, Inc.) in treating patients with ovarian, fallopian tube, or primary peritoneal cancer that has...
Phase 1
Bethesda, Maryland, United States and 1 other location
followed by maintenance durvalumab and bevacizumab or durvalumab, bevacizumab and olaparib in patients with newly diagnosed advanced ovarian ...
Phase 3
Towson, Maryland, United States and 213 other locations
carcinoma 1 (NY-ESO-1) peptide vaccine as a priming mechanism to prevent anti-PD1 resistance in patients with platinum-refractory stage III/IV ovarian...
Phase 2
Washington, District of Columbia, United States and 1 other location
the safety and efficacy of avutometinib (VS-6766) monotherapy and in combination with defactinib in subjects with recurrent Low-Grade Serous Ovarian...
Phase 2
Glenn Dale, Maryland, United States and 46 other locations
(PK), and pharmacodynamics (PD) of ZN-c3 in combination with niraparib and of ZN-c3 Monotherapy in subjects with platinum-resistant ovarian ....
Phase 1, Phase 2
Fairfax, Virginia, United States and 19 other locations
Phase 1 trial to study the safety, pharmacokinetic and Preliminary Efficacy of STRO-002 in combination with Bevacizumab.
Phase 1
Fairfax, Virginia, United States and 5 other locations
Clinical trials
Research sites
Resources
Legal